View in EDS HTML Full Text PDF Full Text

Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia.
Authors: Little JS; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Coughlin C; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Hsieh C; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lanza M; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Huang WY; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kumar A; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dandawate T; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Tucker R; Harvard Medical School, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Gable P; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Vazquez Deida AA; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Moulton-Meissner H; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Stevens V; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McAllister G; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ewing T; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Diaz M; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Glowicz J; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Winkler ML; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Microbiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Pecora N; Harvard Medical School, Boston, Massachusetts, USA.; Division of Microbiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kubiak DW; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Pearson JC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Luskin MR; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sherman AC; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Woolley AE; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Brandeburg C; Massachusetts Department of Public Health, Boston, Massachusetts, USA., Bolstorff B; Massachusetts Department of Public Health, Boston, Massachusetts, USA., McHale E; Massachusetts Department of Public Health, Boston, Massachusetts, USA., Fortes E; Massachusetts Department of Public Health, Boston, Massachusetts, USA., Doucette M; Massachusetts Department of Public Health, Boston, Massachusetts, USA., Smole S; Massachusetts Department of Public Health, Boston, Massachusetts, USA., Bunnell C; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gross A; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Platt D; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Desai S; Harvard Medical School, Boston, Massachusetts, USA.; Department of Quality and Safety, Brigham and Women's Hospital, Boston, Massachusetts, USA., Fiumara K; Harvard Medical School, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA., Issa NC; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Baden LR; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rhee C; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts, USA., Klompas M; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts, USA., Baker MA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Infection Control, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Healthcare Institute, Boston, Massachusetts, USA.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jan 25; Vol. 11 (3), pp. ofae048. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2328-8957
DOI:10.1093/ofid/ofae048